| Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease KM de Lange, L Moutsianas, JC Lee, CA Lamb, Y Luo, NA Kennedy, ... Nature genetics 49 (2), 256-261, 2017 | 1193 | 2017 |
| The medical management of paediatric Crohn’s disease: an ECCO-ESPGHAN guideline update PF Van Rheenen, M Aloi, A Assa, J Bronsky, JC Escher, UL Fagerberg, ... Journal of Crohn's and Colitis 15 (2), 171-194, 2021 | 454 | 2021 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172, 2015 | 329 | 2015 |
| Rising incidence of pediatric inflammatory bowel disease in Scotland P Henderson, R Hansen, FL Cameron, K Gerasimidis, P Rogers, ... Inflammatory bowel diseases 18 (6), 999-1005, 2011 | 273 | 2011 |
| The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis P Henderson, NH Anderson, DC Wilson The American journal of gastroenterology 109 (5), 637-645, 2014 | 270 | 2014 |
| Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway JC Lee, M Espéli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ... Cell 155 (1), 57-69, 2013 | 259 | 2013 |
| Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review ME Kuenzig, SG Fung, L Marderfeld, JWY Mak, GG Kaplan, SC Ng, ... Gastroenterology 162 (4), 1147-1159. e4, 2022 | 257 | 2022 |
| Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway ER Nimmo, JG Prendergast, MC Aldhous, NA Kennedy, P Henderson, ... Inflammatory bowel diseases 18 (5), 889-899, 2011 | 205 | 2011 |
| IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology GR Jones, M Lyons, N Plevris, PW Jenkinson, C Bisset, C Burgess, S Din, ... Gut 68 (11), 1953-1960, 2019 | 178 | 2019 |
| Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease P Henderson, JE van Limbergen, J Schwarze, DC Wilson Inflammatory bowel diseases 17 (1), 382-395, 2010 | 171 | 2010 |
| The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease P Henderson, A Casey, SJ Lawrence, NA Kennedy, K Kingstone, ... The American journal of gastroenterology 107 (6), 941-949, 2012 | 161 | 2012 |
| The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1 M Depner, S Fuchs, J Raabe, N Frede, C Glocker, R Doffinger, ... Journal of clinical immunology 36, 73-84, 2016 | 145 | 2016 |
| The rising incidence of celiac disease in Scotland LE White, VM Merrick, E Bannerman, RK Russell, D Basude, ... Pediatrics 132 (4), e924-e931, 2013 | 136 | 2013 |
| Genetics of childhood-onset inflammatory bowel disease P Henderson, JE van Limbergen, DC Wilson, J Satsangi, RK Russell Inflammatory bowel diseases 17 (1), 346-361, 2010 | 110 | 2010 |
| Faecal calprotectin in suspected paediatric inflammatory bowel disease PLJ Degraeuwe, MPA Beld, M Ashorn, RB Canani, AS Day, A Diamanti, ... Journal of pediatric gastroenterology and nutrition 60 (3), 339-346, 2015 | 103 | 2015 |
| Adeno-associated virus 2 infection in children with non-A–E hepatitis A Ho, R Orton, R Tayler, P Asamaphan, V Herder, C Davis, L Tong, ... Nature 617 (7961), 555-563, 2023 | 100 | 2023 |
| The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility International Multiple Sclerosis Genetics Consortium, NA Patsopoulos, ... BioRxiv, 143933, 2017 | 99 | 2017 |
| Inflammatory bowel disease drugs: a focus on autophagy KM Hooper, PG Barlow, C Stevens, P Henderson Journal of Crohn's and Colitis 11 (1), 118-127, 2017 | 93 | 2017 |
| The intermediate filament protein, vimentin, is a regulator of NOD2 activity C Stevens, P Henderson, ER Nimmo, DC Soares, B Dogan, KW Simpson, ... Gut 62 (5), 695-707, 2013 | 85 | 2013 |
| NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease T Schwerd, RV Bryant, S Pandey, M Capitani, L Meran, JB Cazier, J Jung, ... Mucosal immunology 11 (2), 562, 2018 | 83 | 2018 |
Richard HansenClinical Reader in Child Health at University of DundeeVerified email at dundee.ac.uk
